Our findings indicate that silibinin effectively suppresses the expression of EGFR mRNA, a crucial compound in the PAM signaling pathway, along with several downstream genes, including PI3K, AKT-1, PTEN, and mTOR mRNAs, in cancer cells (Fig. 2). This evidence concerns the gene EGFR and cancer.